VST insider sale notice: 21,365 shares, $4.43M via Fidelity
Rhea-AI Filing Summary
Vistra Corp. (VST) filed a Form 144 disclosing a proposed sale of 21,365 common shares with an aggregate market value of $4,434,403.42, representing part of the company's 338,820,324 outstanding shares. The notice lists Fidelity Brokerage Services LLC as the broker and an approximate sale date of 10/09/2025. The securities were acquired under an option granted on 04/09/2018 and the filing indicates payment in cash on 10/09/2025.
The filing also lists multiple recent sales by James A. Burke between 09/10/2025 and 10/08/2025, showing repeated dispositions of common shares with gross proceeds reported for each trade. The filer confirms the standard representation that they are not aware of undisclosed material adverse information about the issuer.
Positive
- Required disclosure filed under Rule 144 showing proposed sale details
- Acquisition source documented (option granted on 04/09/2018) supporting the sale legitimacy
Negative
- Substantial insider selling activity: multiple sales by James A. Burke across 09/10/2025–10/08/2025
- No Rule 10b5-1 plan date provided on the Form 144 to indicate pre-planned sales
Insights
Significant insider dispositions recorded over several weeks; a new option exercise sale is planned.
The filing shows a proposed sale of $4,434,403.42 for 21,365 shares via Fidelity Brokerage Services, acquired via an option granted on 04/09/2018 and paid in cash on 10/09/2025. Multiple prior sales by James A. Burke from 09/10/2025 to 10/08/2025 are itemized with gross proceeds for each trade.
The pattern is factual disclosure of insider liquidity rather than a statement about company performance; monitor subsequent Form 4 or Form 5 filings for continuing dispositions or indications of a structured trading plan within the next few weeks.
Disclosure aligns with Rule 144 procedures; no trading-plan date is indicated on this form.
The filer represents compliance with Rule 144 by filing this notice and affirms no known undisclosed material adverse information. The record lists the acquisition source as the issuer and an option grant date, which documents the insider's basis for the sale.
Governance stakeholders should note the absence of a declared Rule 10b5-1 adoption date on the form; if a written trading plan exists, a separate filing or notation would clarify whether sales are pre‑planned within the coming months.